Ana Bosch

3.6k citations
43 papers · 1.6k indexed · h-index 16
Topics
HER2/EGFR in Cancer Research (11 papers)Advanced Breast Cancer Therapies (11 papers)Breast Cancer Treatment Studies (11 papers)
Partner nations
SwedenSpainUnited States

In The Last Decade

Ana Bosch

41 papers receiving 1.6k citations

Peers

Ana Bosch
Comparison fields: 5 of 104
  • Oncology 832
  • Molecular Biology 661
  • Cancer Research 545
  • Pulmonary and Respiratory Medicine 390
  • Genetics 183
Replace Claudio Vernieri with:
Claudio Vernieri Italy
Wenjin Yin China
Woo Chul Noh South Korea
Peng Yuan China
Fiona M. Blows United Kingdom
Fariba Behbod United States
Jianjun He China
Andrew H. Beck United States
Akiko Kokubu Japan
Yue Gong China
Ana Bosch relative to Claudio Vernieri Italy Claudio Vernieri's profile →
Citations per field
00.5×4.9×
Claudio Vernieri · 1×
Citations per year

Countries citing papers authored by Ana Bosch

Since Specialization
Citations

This map shows the geographic impact of Ana Bosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Bosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Bosch more than expected).

Fields of papers citing papers by Ana Bosch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Bosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Bosch. The network helps show where Ana Bosch may publish in the future.

Co-authorship network of co-authors of Ana Bosch

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Bosch. A scholar is included among the top collaborators of Ana Bosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Bosch. Ana Bosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 6
3 2
4 0
5 14
6 3
7 38
8 5
9 25
10 4
11 110
12 54
13 3
14 435
15 37
16 213
17 12
18 0
19
Intervención de restauración en los puentes de Trinidad y Serranos de Valencia
1
20 13

About Ana Bosch

Ana Bosch is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 1.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Advanced Breast Cancer Therapies (11 papers) and Breast Cancer Treatment Studies (11 papers). The work is most often cited by research in Cancer Research (545 citations), Oncology (832 citations) and Pulmonary and Respiratory Medicine (390 citations). Ana Bosch has collaborated with scholars based in Sweden, Spain and United States. Frequent co-authors include Aňa Lluch, Pîlar Eroles, José Alejandro Pérez Fidalgo, Juan R. Vinã, Rosa Zaragozá, Isabel Chirivella, Susana Roselló, Signe Borgquist, Amelia Insa and Elisa García-Garré. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026